N-甲基-D-天冬氨酸（NMDA）拮抗剂美金刚可改善帕金森病中左旋多巴诱发的运动障碍和“开-关”现象。 - Suppr

NMDA antagonist memantine improves levodopa-induced dyskinesias and "on-off" phenomena in Parkinson's disease.

作者信息

Varanese Sara, Howard Jonathan, Di Rocco Alessandro

出版信息

Mov Disord. 2010 Mar 15;25(4):508-10. doi: 10.1002/mds.22917.

DOI:10.1002/mds.22917

PMID:20014061

Abstract

摘要

相似文献

NMDA antagonist memantine improves levodopa-induced dyskinesias and "on-off" phenomena in Parkinson's disease.

Mov Disord. 2010 Mar 15;25(4):508-10. doi: 10.1002/mds.22917.

Unexpected improvement in levodopa-induced dyskinesia and on-off phenomena after introduction of memantine for treatment of Parkinson's disease dementia.

J Am Geriatr Soc. 2013 Jan;61(1):170-2. doi: 10.1111/jgs.12058.

Effect of memantine (NMDA antagonist) on Parkinson's disease: a double-blind crossover randomized study.

Clin Neuropharmacol. 1999 Sep-Oct;22(5):273-6.

[Memantine can relieve certain symptoms in Parkinson disease. Improvement achieved in two out of three described cases with dyskinesia and cognitive failure].

Lakartidningen. 2004 Jun 3;101(23):2003-6.

Levodopa-dyskinesia incidence by age of Parkinson's disease onset.

Mov Disord. 2005 Mar;20(3):342-4. doi: 10.1002/mds.20360.

The use of NMDA antagonist memantine in drug-resistant dyskinesias resulting from L-dopa.

Mov Disord. 2000 Sep;15(5):1016-7. doi: 10.1002/1531-8257(200009)15:5<1016::aid-mds1042>3.0.co;2-j.

Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease.

Mov Disord. 2005 Sep;20(9):1205-9. doi: 10.1002/mds.20563.

Conjugate eye deviations as dyskinesias induced by levodopa in Parkinson's disease.

Mov Disord. 1998 Jul;13(4):731-4. doi: 10.1002/mds.870130421.

The effect of levetiracetam on levodopa induced dyskinesia in patients with Parkinson's disease.

Parkinsonism Relat Disord. 2005 Aug;11(5):333-4. doi: 10.1016/j.parkreldis.2004.11.003.

Current controversies: levodopa in the treatment of Parkinson's disease.

Mov Disord. 2005 May;20(5):642-3; author reply 643-4. doi: 10.1002/mds.20444.

引用本文的文献

Intrastriatal Memantine Infusion Dampens Levodopa-Induced Dyskinesia and Motor Deficits in a Mouse Model of Hemiparkinsonism.

Front Neurol. 2019 Dec 5;10:1258. doi: 10.3389/fneur.2019.01258. eCollection 2019.

Safinamide: an add-on treatment for managing Parkinson's disease.

Clin Pharmacol. 2018 Apr 5;10:31-41. doi: 10.2147/CPAA.S137740. eCollection 2018.

Glutamatergic mechanisms in L-DOPA-induced dyskinesia and therapeutic implications.

J Neural Transm (Vienna). 2018 Aug;125(8):1225-1236. doi: 10.1007/s00702-018-1846-8. Epub 2018 Jan 31.

Efficacy and safety of perampanel in Parkinson's disease. A systematic review with meta-analysis.

J Neurol. 2018 Apr;265(4):733-740. doi: 10.1007/s00415-017-8681-y. Epub 2017 Nov 20.

Current Nondopaminergic Therapeutic Options for Motor Symptoms of Parkinson's Disease.

Chin Med J (Engl). 2017 Aug 5;130(15):1856-1866. doi: 10.4103/0366-6999.211555.

Clinical Pharmacokinetics and Pharmacodynamics of Safinamide.

Clin Pharmacokinet. 2017 Mar;56(3):251-261. doi: 10.1007/s40262-016-0449-5.

Memantine and Kynurenic Acid: Current Neuropharmacological Aspects.

Curr Neuropharmacol. 2016;14(2):200-9. doi: 10.2174/1570159x14666151113123221.

Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson's disease.

CNS Drugs. 2014 Dec;28(12):1155-84. doi: 10.1007/s40263-014-0205-z.

Advances in non-dopaminergic treatments for Parkinson's disease.

Front Neurosci. 2014 May 22;8:113. doi: 10.3389/fnins.2014.00113. eCollection 2014.

Therapeutic potential of targeting glutamate receptors in Parkinson's disease.

J Neural Transm (Vienna). 2014 Aug;121(8):861-80. doi: 10.1007/s00702-014-1176-4. Epub 2014 Feb 21.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

NMDA antagonist memantine improves levodopa-induced dyskinesias and "on-off" phenomena in Parkinson's disease.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

NMDA antagonist memantine improves levodopa-induced dyskinesias and "on-off" phenomena in Parkinson's disease.

作者信息

出版信息

相似文献

引用本文的文献